Article
[Mechanism on androgen-independent progression of prostate cancer].
Nihon rinsho. Japanese journal of clinical medicine - 1 May 1997
Shimazaki J, Akakura K, Furuya Y, Ito H
Abstract excerpt
Eighty percent of prostate cancer with metastasis respond to androgen ablasion, showing initial androgen-sensitive growth. However, more than half of responders gradually loses dependency up to 5 years. Animal experiments reveal that loss of androgen sensitivity is attributable to complex reasons...
Topics
- Androgen Antagonists
- Androgens
- Animals
- Disease Progression
- Drug Resistance, Neoplasm
- Gene Expression Regulation, Neoplastic
- Genes, Tumor Suppressor
- Humans
- Male
- Mutation
- Orchiectomy
- Prostatic Neoplasms
